Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
5 studies found for:    12860938 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Active, not recruiting
Has Results
Phase II Study of IMC-A12 in Patients With Mesothelioma Who Have Been Previously Treated With Chemotherapy
Conditions: Pleural Mesothelioma;   Peritoneal Mesothelioma
Intervention: Drug: IMC-A12
2 Active, not recruiting Combination of Gemcitabine and Imatinib Mesylate in Pemetrexed-pretreated Patients With Pleural Mesothelioma
Condition: Mesothelioma, Malignant
Interventions: Drug: Gemcitabine;   Drug: Imatinib mesylate
3 Recruiting Autologous Dendritic Cell Vaccination in Mesothelioma
Condition: Malignant Pleural Mesothelioma
Intervention: Biological: dendritic cell vaccination plus chemotherapy
4 Active, not recruiting Response Evaluation in Malignant Pleural Mesothelioma
Condition: Malignant Pleural Mesothelioma
Intervention:
5 Not yet recruiting PembROlizuMab Immunotherapy Versus Standard Chemotherapy for Advanced prE-treated Malignant Pleural Mesothelioma
Condition: Pleural Mesothelioma Malignant Advanced
Interventions: Drug: Pembrolizumab;   Drug: Gemcitabine;   Drug: Vinorelbine

Study has passed its completion date and status has not been verified in more than two years.